Description
The OncoMate™ MSI Dx Interpretive software provides an accurate automated MSI result with minimal expertise. Raw data generated with the OncoMate™ MSI Dx Analysis System is imported into the software where it is evaluated for data quality and an automated MSI result is determined. In a study of 154 colorectal cancer cases the OncoMate™ MSI Dx Analysis System, in conjunction with the OncoMate MSI Dx Interpretive Software, generated an MSI determination with a 97.8% positive percent agreement and a 97.2% negative percent agreement with MMR by IHC